Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-02-24 @ 5:50 AM
Study NCT ID:
NCT02141451
Status:
COMPLETED
Last Update Posted:
2020-02-19
First Post:
2014-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2019-01-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-15
First Submit QC Date:
None
Study First Post Date:
2014-05-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-23
Results First Submit QC Date:
None
Results First Post Date:
2020-02-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-06
Last Update Post Date:
2020-02-19
Last Update Post Date Type:
ACTUAL